<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">71596</article-id><article-id pub-id-type="doi">10.7554/eLife.71596</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group></article-categories><title-group><article-title>USP28 deletion and small molecule inhibition destabilises c-MYC and elicits regression of squamous cell lung carcinoma</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-220538"><name><surname>Ruiz</surname><given-names>E Josue</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183566"><name><surname>Pinto-Fernandez</surname><given-names>Adan</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220539"><name><surname>Turnbull</surname><given-names>Andrew P</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-220540"><name><surname>Lan</surname><given-names>Linxiang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220541"><name><surname>Charlton</surname><given-names>Thomas M</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183981"><name><surname>Scott</surname><given-names>Hannah C</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220542"><name><surname>Damianou</surname><given-names>Andreas</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220543"><name><surname>Vere</surname><given-names>George</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1154-5212</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220583"><name><surname>Riising</surname><given-names>Eva M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220584"><name><surname>Da Costa</surname><given-names>Clive</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220586"><name><surname>Krajewski</surname><given-names>Wojciech W</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf3"/></contrib><contrib contrib-type="author" id="author-220588"><name><surname>Guerin</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf4"/></contrib><contrib contrib-type="author" id="author-220592"><name><surname>Kearns</surname><given-names>Jeffrey D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7261-5096</contrib-id><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf5"/></contrib><contrib contrib-type="author" id="author-183582"><name><surname>Ioannidis</surname><given-names>Stephanos</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf6"/></contrib><contrib contrib-type="author" id="author-244120"><name><surname>Katz</surname><given-names>Marie</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf7"/></contrib><contrib contrib-type="author" id="author-244121"><name><surname>McKinnon</surname><given-names>Crystal</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf8"/></contrib><contrib contrib-type="author" id="author-183578"><name><surname>O'Connell</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf9"/></contrib><contrib contrib-type="author" id="author-250465"><name><surname>Moncaut</surname><given-names>Natalia</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-214666"><name><surname>Rosewell</surname><given-names>Ian</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-100848"><name><surname>Nye</surname><given-names>Emma</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-220604"><name><surname>Jones</surname><given-names>Neil</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf10"/></contrib><contrib contrib-type="author" id="author-183565"><name><surname>Heride</surname><given-names>Claire</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1927-9577</contrib-id><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf11"/></contrib><contrib contrib-type="author" id="author-183977"><name><surname>Gersch</surname><given-names>Malte</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-244122"><name><surname>Wu</surname><given-names>Min</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf12"/></contrib><contrib contrib-type="author" id="author-244123"><name><surname>Dinsmore</surname><given-names>Christopher J</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf13"/></contrib><contrib contrib-type="author" id="author-183576"><name><surname>Hammonds</surname><given-names>Tim R</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf14"/></contrib><contrib contrib-type="author" id="author-244124"><name><surname>Kim</surname><given-names>Sunkyu</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf15"/></contrib><contrib contrib-type="author" id="author-9908"><name><surname>Komander</surname><given-names>David</given-names></name><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf16"/></contrib><contrib contrib-type="author" id="author-21140"><name><surname>Urbe</surname><given-names>Sylvie</given-names></name><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf17"/></contrib><contrib contrib-type="author" id="author-147043"><name><surname>Clague</surname><given-names>Michael J</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3355-9479</contrib-id><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="other" rid="par-1"/><xref ref-type="fn" rid="conf18"/></contrib><contrib contrib-type="author" corresp="yes" id="author-27576"><name><surname>Kessler</surname><given-names>Benedikt M</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8160-2446</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-5"/><xref ref-type="other" rid="par-6"/><xref ref-type="other" rid="par-7"/><xref ref-type="fn" rid="conf19"/></contrib><contrib contrib-type="author" corresp="yes" id="author-220609"><name><surname>Behrens</surname><given-names>Axel</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1557-1143</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf20"/></contrib><aff id="aff1"><institution content-type="dept">King's College London</institution>, <institution>The Francis Crick Institute</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Target Discovery Institute, Nuffield Department of Medicine</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff3"><institution content-type="dept">London Bioscience Innovation Centre</institution>, <institution>CRUK Therapeutic Discovery Laboratories</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Target Discovery Institute, Centre for Medicines Discovery, Nuffield Department of Medicine</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">Watertown, Massachusetts 02472, USA</institution>, <institution>Forma Therapeutics</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Translational Medicine, PK Sciences Modeling &amp; Simulation</institution>, <institution>Novartis Institutes of BioMedical Research</institution>, <addr-line><named-content content-type="city">Cambridge</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution>Forma Therapeutics</institution>, <addr-line><named-content content-type="city">Watertown, MA</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution>FORMA Therapeutics</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution>University College London</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff10"><institution content-type="dept">Genetic Modification Service</institution>, <institution>The Francis Crick Institute</institution>, <addr-line><named-content content-type="city">Londonj</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff11"><institution content-type="dept">Experimental Histopathology Laboratory</institution>, <institution>Francis Crick Institute</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff12"><institution content-type="dept">Target Validation and Disease Positioning</institution>, <institution>CRUK Therapeutic Discovery Laboratories</institution>, <addr-line><named-content content-type="city">London</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff13"><institution>Max Planck Institut, Dortmund</institution>, <addr-line><named-content content-type="city">Dortmund</named-content></addr-line>, <country>Germany</country></aff><aff id="aff14"><institution>Walter and Eliza Hall Institute of Medical Research</institution>, <addr-line><named-content content-type="city">Parkville</named-content></addr-line>, <country>Australia</country></aff><aff id="aff15"><institution>Liverpool University</institution>, <addr-line><named-content content-type="city">Liverpool</named-content></addr-line>, <country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-13853"><name><surname>Golemis</surname><given-names>Erica A</given-names></name><role>Reviewing editor</role><aff><institution>Fox Chase Cancer Center</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>benedikt.kessler@ndm.ox.ac.uk</email> (BK);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>axel.behrens@icr.ac.uk</email> (AB);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>12</day><month>10</month><year>2021</year></pub-date><volume>10</volume><elocation-id>e71596</elocation-id><history><date date-type="received"><day>24</day><month>06</month><year>2021</year></date><date date-type="accepted"><day>10</day><month>10</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Ruiz et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Ruiz et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-71596-v1.pdf"/><abstract><p>Lung squamous cell carcinoma (LSCC) is a considerable global health burden, with an incidence of over 600,000 cases per year. Treatment options are limited, and patient 5-year survival rate is less than 5%. The ubiquitin specific protease 28 (USP28) has been implicated in tumorigenesis through its stabilization of the oncoproteins c-MYC, c-JUN and Dp63. Here, we show that genetic inactivation of <italic>Usp28</italic> induced regression of established murine LSCC lung tumours. We developed a small molecule that inhibits USP28 activity in the low nanomole range. While displaying cross-reactivity against the closest homologue USP25, this inhibitor showed a high degree of selectivity over other deubiquitinases. USP28 inhibitor treatment resulted in a dramatic decrease in c-MYC, c-JUN and Dp63 proteins levels and consequently induced substantial regression of autochthonous murine LSCC tumors and human LSCC xenografts, thereby phenocopying the effect observed by genetic deletion. Thus, USP28 may represent a promising therapeutic target for the treatment of squamous cell lung carcinoma.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>Forma Therapeutics</institution></institution-wrap></funding-source><award-id>2013-2019</award-id><principal-award-recipient><name><surname>Ruiz</surname><given-names>E Josue</given-names></name><name><surname>Pinto-Fernandez</surname><given-names>Adan</given-names></name><name><surname>Turnbull</surname><given-names>Andrew P</given-names></name><name><surname>Lan</surname><given-names>Linxiang</given-names></name><name><surname>Charlton</surname><given-names>Thomas M</given-names></name><name><surname>Scott</surname><given-names>Hannah C</given-names></name><name><surname>Damianou</surname><given-names>Andreas</given-names></name><name><surname>Vere</surname><given-names>George</given-names></name><name><surname>Riising</surname><given-names>Eva M</given-names></name><name><surname>Da Costa</surname><given-names>Clive</given-names></name><name><surname>Krajewski</surname><given-names>Wojciech W</given-names></name><name><surname>Guerin</surname><given-names>David</given-names></name><name><surname>Kearns</surname><given-names>Jeffrey D</given-names></name><name><surname>Ioannidis</surname><given-names>Stephanos</given-names></name><name><surname>Katz</surname><given-names>Marie</given-names></name><name><surname>McKinnon</surname><given-names>Crystal</given-names></name><name><surname>O'Connell</surname><given-names>Jonathan</given-names></name><name><surname>Moncaut</surname><given-names>Natalia</given-names></name><name><surname>Rosewell</surname><given-names>Ian</given-names></name><name><surname>Nye</surname><given-names>Emma</given-names></name><name><surname>Jones</surname><given-names>Neil</given-names></name><name><surname>Heride</surname><given-names>Claire</given-names></name><name><surname>Gersch</surname><given-names>Malte</given-names></name><name><surname>Wu</surname><given-names>Min</given-names></name><name><surname>Dinsmore</surname><given-names>Christopher J</given-names></name><name><surname>Hammonds</surname><given-names>Tim R</given-names></name><name><surname>Kim</surname><given-names>Sunkyu</given-names></name><name><surname>Komander</surname><given-names>David</given-names></name><name><surname>Urbe</surname><given-names>Sylvie</given-names></name><name><surname>Clague</surname><given-names>Michael J</given-names></name><name><surname>Kessler</surname><given-names>Benedikt M</given-names></name><name><surname>Behrens</surname><given-names>Axel</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100017008</institution-id><institution>Cancer Research UK Manchester Centre</institution></institution-wrap></funding-source><award-id>FC001039</award-id><principal-award-recipient><name><surname>Behrens</surname><given-names>Axel</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>FC001039</award-id><principal-award-recipient><name><surname>Behrens</surname><given-names>Axel</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>FC001039</award-id><principal-award-recipient><name><surname>Behrens</surname><given-names>Axel</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010269</institution-id><institution>Wellcome Trust</institution></institution-wrap></funding-source><award-id>097813/Z/11/Z</award-id><principal-award-recipient><name><surname>Kessler</surname><given-names>Benedikt M</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000266</institution-id><institution>Engineering and Physical Sciences Research Council</institution></institution-wrap></funding-source><award-id>EP/N034295/1</award-id><principal-award-recipient><name><surname>Kessler</surname><given-names>Benedikt M</given-names></name></principal-award-recipient></award-group><award-group id="par-7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004789</institution-id><institution>John Fell Fund, University of Oxford</institution></institution-wrap></funding-source><award-id>133/075</award-id><principal-award-recipient><name><surname>Kessler</surname><given-names>Benedikt M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Andrew P Turnbull, Andrew P Turnbull is affiliated with the CRUK Therapeutic Discovery Laboratories at the Crick Institute, for which no financial interests have been declared.APT declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf3"><p>Wojciech W Krajewski, Wojciech W Krajewski is affiliated with the CRUK Therapeutic Discovery Laboratories at the Crick Institute, for which no financial interests have been declared. WWK declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf4"><p>David Guerin, Dave Guerin is affiliated with Constellation Pharmaceuticals (Boston, USA), for which no financial interests have been declared.DG declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf5"><p>Jeffrey D Kearns, Jeffrey Kearns is affiliated with the Novartis Institutes for BioMedical Research (Boston, USA), for which no financial interests have been declared.JK declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf6"><p>Stephanos Ioannidis, Stephanos Ioannidis is affiliated with H3 Biomedicine (Cambridge, MA, USA), for which no financial interests have been declared.SI declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf7"><p>Marie Katz, Marie Katz is affiliated with Valo Health (Boston, USA), for which no financial interests have been declared.MK declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf8"><p>Crystal McKinnon, Crystal McKinnon is affiliated with Valo Health (Boston, USA), for which no financial interests have been declared.CM declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf9"><p>Jonathan O'Connell, Johnathan O'Connell is affiliated with Valo Health (Boston, USA), for which no financial interests have been declared.JOC declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf10"><p>Neil Jones, Neil Jones is affiliated with the CRUK Therapeutic Discovery Laboratories at the Crick Institute, for which no financial interests have been declared.NJ declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf11"><p>Claire Heride, Claire Heride is affiliated with the CRUK Therapeutic Discovery Laboratories at the Crick Institute, for which no financial interests have been declared.CH declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf12"><p>Min Wu, Min Wu  is affiliated with Disc Medicine  (Cambridge, MA, USA), for which no financial interests have been declared.MW declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf13"><p>Christopher J Dinsmore, Christopher J Dinsmore  is affiliated with Disc Medicine  (Cambridge, MA, USA), for which no financial interests have been declared.CJD declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf14"><p>Tim R Hammonds, Tim R Hammonds is affiliated with the CRUK Therapeutic Discovery Laboratories at the Crick Institute, for which no financial interests have been declared.TRH declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf15"><p>Sunkyu Kim, Sunkyu Kim is affiliated with Incyte (Wilmington, DE, USA), for which no financial interests have been declared.SK declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf16"><p>David Komander, DK declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf17"><p>Sylvie Urbe, SU declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf18"><p>Michael J Clague, MJC declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf19"><p>Benedikt M Kessler, BMK declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf20"><p>Axel Behrens, AB declares competing financial interests due to financial support for the project described in this manuscript by Forma Therapeutics, Watertown, MA, USA..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal experiments were approved by the Francis Crick Institute Animal Ethics Committee and conformed to UK Home Office regulations under the Animals (Scientific Procedures) Act 1986 including Amendment Regulations 2012.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>For all figures with graphs we provide source data files in the Supplemental Information section. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with an internal ID of PXD469830.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Ruiz E et al</collab></person-group><year iso-8601-date="2021">2021</year><source>Data set title: SP28 deletion and small molecule inhibition destabilises c-Myc and elicits regression of squamous cell lung carcinoma</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/pride/archive/projects/PXD469830">https://www.ebi.ac.uk/pride/archive/projects/PXD469830</ext-link><comment>PXD469830</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Hammermann et al</collab></person-group><year iso-8601-date="2012">2012</year><source>Genetic alterations in USP28 gene in human LSCC</source><ext-link ext-link-type="uri" xlink:href="http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/LUSC/20160128/">http://gdac.broadinstitute.org/runs/stddata__2016_01_28/data/LUSC/20160128/</ext-link><comment>LSCC TCGA data</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-71596-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>